2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)
Files
Publication date
2016-10-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
apolipoprotein B, cholesterol, dyslipidaemias, high-density lipoproteins, lipoprotein remnants, low-density lipoproteins, total cardiovascular risk, treatment, adherence, treatment, drugs, treatment, lifestyle, triglycerides, Taverne, Cardiology and Cardiovascular Medicine, Journal Article
Citation
Catapano, A L, Graham, I, De Backer, G, Wiklund, O, Chapman, M J, Drexel, H, Hoes, A W, Jennings, C S, Landmesser, U, Pedersen, T R, Reiner, Ž, Riccardi, G, Taskinen, M R, Tokgozoglu, L, Verschuren, W M M, Vlachopoulos, C, Wood, D A & Zamorano, J L 2016, '2016 ESC/EAS Guidelines for the Management of Dyslipidaemias : The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)', Atherosclerosis, vol. 253, pp. 281-344. https://doi.org/10.1016/j.atherosclerosis.2016.08.018